Suzette Dutch
Fondateur chez Triathlon Medical Venture Partners LLC
Profil
Suzette DutchSuzette Dutch, Managing Partner of Triathlon Medical Ventures, has 20 years venture investing and 10 years operating experience in pharmaceuticals, surgical devices and diagnostics.
At Senmed she served on the investment committee from its creation in 1987 and led the strategic planning, clinical/regulatory, market and business development due diligence efforts for start-ups through later stage investments.
Previously she was responsible for strategic marketing for Sentron’s surgical stapling business until its sale to Ethicon.
Prior to that she held various positions in clinical studies design, market research, and corporate planning at SmithKline integrating the acquisitions of Allergan, Beckman, and Clinical Laboratories.
She has an MBA from Wharton in Finance and Decision Science, and a BA in economics from Case Western Reserve University.
Postes actifs de Suzette Dutch
| Sociétés | Poste | Début |
|---|---|---|
Triathlon Medical Venture Partners LLC
 Triathlon Medical Venture Partners LLC Investment ManagersFinance Triathlon Medical Venture Partners LLC (Triathlon Medical Venture) is a venture capital firm founded in 2004 by Dennis Costello and John Rice. The firm is headquartered in Cincinnati, Ohio with additional offices in Indianapolis and Louisville. | Fondateur | 01/01/2004 |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Directeur/Membre du Conseil | - |
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH. | Directeur/Membre du Conseil | - |
Anciens postes connus de Suzette Dutch
| Sociétés | Poste | Fin |
|---|---|---|
| Senmed Medical Ventures | Corporate Officer/Principal | 01/01/2003 |
Sencorp, Inc.
 Sencorp, Inc. Industrial MachineryProducer Manufacturing Sencorp, Inc. designs, manufactures, and sells thermoforming and sealing machineries. Its products include thermo formers, blister sealers, laboratory sealers, and other parts for the packaging, electronics, medical, material testing, pharmaceutical, and automotive industries. The company was founded in 1946 and is headquartered in Hyannis, MA. | Corporate Officer/Principal | 31/12/1986 |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Directeur/Membre du Conseil | - |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Tolera Therapeutics, Inc.
 Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Président | - |
Formation de Suzette Dutch
| Case Western Reserve University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Triathlon Medical Venture Partners LLC
Triathlon Medical Venture Partners LLC Investment ManagersFinance Triathlon Medical Venture Partners LLC (Triathlon Medical Venture) is a venture capital firm founded in 2004 by Dennis Costello and John Rice. The firm is headquartered in Cincinnati, Ohio with additional offices in Indianapolis and Louisville. | Finance |
| Senmed Medical Ventures | Finance |
Sencorp, Inc.
Sencorp, Inc. Industrial MachineryProducer Manufacturing Sencorp, Inc. designs, manufactures, and sells thermoforming and sealing machineries. Its products include thermo formers, blister sealers, laboratory sealers, and other parts for the packaging, electronics, medical, material testing, pharmaceutical, and automotive industries. The company was founded in 1946 and is headquartered in Hyannis, MA. | Producer Manufacturing |
Renal Solutions, Inc.
 Renal Solutions, Inc. Medical SpecialtiesHealth Technology Renal Solutions, Inc. develops, manufactures and distributes medical devices for dialysis. It commercializes the Allient Sorbent Hemodialysis Systems, a technology/service solution for the chronic and acute dialysis market. The company was founded by Peter M. DeComo on August 1, 2000 and is headquartered in Warrendale, PA. | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Commercial Services |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH. | Health Services |